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Transplantation of a Peripheral Nerve
with Neural Stem Cells Plus Lithium
Chloride Injection Promote the Recovery
of Rat Spinal Cord Injury
Li-Qun Zhang1, Wen-Ming Zhang1, Lingxiao Deng2,3,
Zi-Xing Xu1, Wen-Bin Lan1, and Jian-Hua Lin1
Abstract
Transplantation of neural stem cells (NSCs) holds great potential for the treatment of spinal cord injury (SCI). However,
transplanted NSCs poorly survive in the SCI environment. We injected NSCs into tibial nerve and transplanted tibial nerve
into a hemisected spinal cord and investigated the effects of lithium chloride (LiCl) on the survival of spinal neurons, axonal
regeneration, and functional recovery. Our results show that most of the transplanted NSCs expressed glial fibrillary acidic
protein, while there was no obvious expression of nestin, neuronal nuclei, or acetyltransferase found in NSCs. LiCl treatment
produced less macrosialin (ED1) expression and axonal degeneration in tibial nerve after NSC injection. Our results also show
that a regimen of LiCl treatment promoted NSC differentiation into NF200-positive neurons with neurite extension into the
host spinal cord. The combination of tibial nerve transplantation with NSCs and LiCl injection resulted in more host
motoneurons surviving in the spinal cord, more regenerated axons in tibial nerve, less glial scar area, and decreased ED1
expression. We conclude that lithium may have therapeutic potential in cell replacement strategies for central nervous system
injury due to its ability to promote survival and neuronal generation of grafted NSCs and reduced host immune reaction.
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Introduction
Neural stem cells (NSCs) can be isolated from both fetal
central nervous system (CNS) tissue1–3 and adult CNS tis-
sue4–6. Under certain conditions, NSCs can differentiate into
neuron, astrocyte, and oligodendrocyte and migrate to dam-
aged areas, replacing degenerated or dead neural cells.
Because of this potential of multidifferentiation, NSCs play
an important role in replacement therapy in CNS injury or
disease. Recent studies found that NSCs have protective
effects in the treatment of multiple sclerosis, amyotrophic
lateral sclerosis, and stroke7–9. Similarly, NSCs can play
several roles in the treatment of spinal cord injury (SCI)10
including replacement of damaged neuronal and glial cells,
remyelination of spared axons, restoration of neuronal cir-
cuitry, and bridging of lesion cavities. They can also enhance
production of neurotrophic factors, anti-inflammatory cyto-
kines, and other molecules to promote tissue sparing and
neovascularization. They may also contribute to establishing
a permissive environment for neural plasticity and axonal
regeneration. Since the local environment is not suitable for
the survival of NSCs after acute SCI, more strategies should
be considered to protect NSCs and to improve their survival
after transplantation to promote functional recovery. Since
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peripheral nerve transplantation for the treatment of SCI had
been studied by many authors, and since transplantation of
NSCs has produced some interesting results in the treatment
of peripheral nerve injury11–14, it is possible that peripheral
nerve could serve as a vehicle to host NSCs and that trans-
plantation of peripheral nerve with NSCs may have some
effects in the repair of damaged spinal cord.
Lithium has been used to treat bipolar disease for over 60
years. Recently, lithium was found to have therapeutic
effects in the treatment of CNS injury and some degenerative
diseases such as stroke, brain and SCI, Alzheimer’s disease,
Parkinson’s disease, and Huntington’s disease15. More
recently, lithium has been found to upregulate the expression
of neurotrophic factors, to promote CNS neurogenesis, to
inhibit apoptosis promoter expression, and to protect brain
tissue in ischemic and traumatic injuries16,17, indicating that
lithium may offer similar protection in the setting of SCI.
Some studies found that lithium promotes NSC proliferation,
neural differentiation, and brain-derived neurotrophic factor
(BDNF) production18. The effects of lithium on NSCs offered
the potential that NSC transplantation plus lithium treatment
may promote functional recovery after SCI. However, few
studies reported on the use of the combination strategy of
NSC transplantation plus lithium in the treatment of SCI.
Based on these theories, we sought to determine whether
the combination strategy of transplantation of peripheral
nerve with NSCs plus lithium treatment can improve func-
tional recovery after SCI. To delineate this possibility, we
employed an in vivo spinal cord hemisection model. Our
findings show that the combination of lithium chloride
(LiCl) and transplantation of tibial nerve with NSCs had
better effects in promoting functional recovery after spinal
cord hemisection injury.
Materials and Methods
Cell Isolation and Culture
Under sterile conditions, spinal cords from E13.5 transgenic
Sprague-Dawley (SD) rats expressing green fluorescent pro-
tein (GFP; a gift from Professor Wutian Wu of University of
Hong Kong) were dissected out and prepared for stem cell
culture following procedures described previously with
modifications1,19,20. Briefly, the spinal cord was separated
from surrounding connective tissue. After peeling off the
meninges and nerve roots, the cord was cut into small pieces
and transferred into a 15 mL centrifuge tube containing Accu-
tase (Invitrogen, Carlsbad, CA, USA) and culture medium
(described below) and dissociated to a single-cell suspension
by gentle mechanical trituration through a fire-polished Pas-
teur pipette. The dissociated cells were filtered through a cell
strainer (BD Falcon, San Jose, CA, USA) and plated onto
poly-L-lysine-/laminin-coated dishes. The culture medium
consisted of Dulbecco’s modified eagle medium (DMEM):
nutrient mixture F- 12 (Invitrogen, Carlsbad, CA, USA),
bovine serum albumin (1 mg/mL, Sigma-Aldrich, St. Louis,
MO, USA), B27 (Invitrogen), N2 (Invitrogen), epidermal
growth factor (20 ng/mL, Peprotech, Rocky Hill, NJ, USA),
basic fibroblast growth factor (20 ng/mL, Peprotech), and
Pen–Strep (100 IU/mL, Invitrogen).
Cells were maintained in an incubator with a humidified
atmosphere containing 5% CO2 at 37
C. The medium was
changed every 2 d. At around 80% confluence, cells were
passaged at the ratio of 1:4 to 1:6 after initial plating. These
passaged cells were designated as “first passage” (P1). When
P1 generation NSCs reached 80% confluence, cells were
harvested and suspended in culture medium at a concentra-
tion of 1.0  105 cells/mL before transplantation.
Ligation of Tibial Nerve and Transplantation of NSCs
Animals were weighed and anesthetized by intraperitoneal
injection of 10% chloral hydrate (0.4 mL/100 g). After an
incision was made in the back of right thigh, the tibial nerve
was exposed, clamped with microforceps, and ligated just
beneath the separation from the common peroneal nerve.
Then, 1 mL of cell suspension containing 1.0 105 NSCs was
slowly injected over 5 min into the distal tibial nerve using
microsyringe, and themicrosyringewas left in place for 2more
minutes after injection. The injection site was closedwith 11-0
suture, and the skin was closed with 1-0 suture. After NSC
injection, animals were randomly divided into 2 groups (12
animals in each group). One group (NSC þ LiCl group)
received daily intraperitoneal injections of LiCl (85 mg/kg
bodyweight, dissolved in distilled water) until euthanasia21.
The other group (NSC þ NS group) received daily intraper-
itoneal injections of saline as the control treatment.
Tissue Processing of Tibial Nerve and
Immunohistochemistry
One week after NSC transplantation, animals were given an
overdose of 10% chloral hydrate (0.5mL/100 g) andwere trans-
cardially perfused and fixed with 4% paraformaldehyde. Tibial
nervewith transplantedNSCswas removed and postfixed over-
night and then transferred to 30% sucrose. Tibial nerve from 1
animal of each group was cut into 20-mm-thick cross sections,
and other tibial nerves were cut into horizontal sections.
Tibial nerve sections were permeabilized and blocked with
0.3% Triton X-100/10% normal goat serum (NGS, Invitrogen)
in 0.01 M phosphate buffered saline (PBS; pH 7.4) for 30 min.
Primary antibodieswere then applied to the sections overnight at
4 C. The following day, sections were incubated with
fluorescein-conjugated secondary antibodies (Alexa 568 goat
antimouse [1:400] or Alexa 568 goat antirabbit [1:400], both
from Invitrogen) for 1 h at room temperature before mounting
with antifade mounting medium. The following primary
antibodies were used: monoclonal mouse antinestin Ab
(1:100,Millipore, Burlington,MA, USA) for identifying NSCs;
monoclonal mouse anti-neuronal nuclei (NeuN) Ab (1:100,
Millipore), mouse anti-acetyltransferase (ChAT) Ab (1:100,
Millipore), and polyclonal rabbit anti-glial fibrillary acidic
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protein (GFAP) Ab (1:100, Sigma-Aldrich) for detecting differ-
entiation of NSCs; and mouse anti-ED1 Ab (1:100, Serotec,
Raleigh, NC, USA) for detecting inflammatory cell infiltration
of tibial nerve.
After immunohistochemical staining, 5 sections were
randomly selected from each sample for taking pictures.
The size of GFAP-, ED1-, and GFP-positive staining area
in each section was measured using ImageJ software (ver-
sion 1.50, National Institutes of Health [NIH]). In brief,
areas of positive staining were enhanced by adjusting
brightness and contrast in ImageJ software. Then, images
were converted to binary images and the sizes of positive
areas were measured. The ratios of GFAP- or ED1-positive
area to GFP-positive area were calculated.
Spinal Cord Hemisection and Transplantation
of Tibial Nerve
Adult female SD rats (180 to 200grams)were randomly divided
into 2 groups, with 1 group receiving NSC injection into the
ligated nerve after tibial nerve ligation (N ¼ 24/group). Each
groupwas divided into 2 subgroups that received either LiCl (85
mg/kg) or NS (2 mL/100 g) via intraperitoneal injection after
surgery (n¼ 12/subgroup). Oneweek after tibial nerve ligation,
animals wereweighed again and anesthetized by intraperitoneal
injection of 10% chloral hydrate (0.4 mL/100 g). The ligated
tibial nerve was exposed and excised for transplantation. The
procedures used for spinal cord hemisection and for preopera-
tive and postoperative animal care were described in detail in
previouspublications20,22.Briefly, after the removal of a 2.8mm
piece of hemicord at T10 on the right side, the prepared tibial
nerve was cut into a 3-mm-long piece, with or without NSC
injection, and implanted into the hemisection gap. The dura and
wound were closed in layers. All animals continued to receive
LiCl (85 mg/kg) or NS (2 mL/100 g) intraperitoneal injection
after the second surgery. All animal handling, surgical proce-
dures, and postoperative care were performed in accordance
with the Guide for the Care and Use of Laboratory Animals23.
Evaluation of Rat Hind Limb Function
Two and four weeks after tibial transplantation, hind limb
locomotor function of each animal was video recorded and
evaluated by two other researchers using blood born barrier
(BBB) scale24.
Tissue Processing of Spinal Cord and
Immunohistochemistry
Four weeks after tibial nerve transplantation, animals were
given an overdose of 10% chloral hydrate (0.5 mL/100 g)
and were transcardially perfused and fixed with 4% paraf-
ormaldehyde. Spinal cord with transplanted tibial nerve was
removed and postfixed overnight and then transferred to
30% sucrose. A 1-cm-long spinal cord segment of each ani-
mal was cut longitudinally at 20 mm thickness.
Spinal cord sections were permeabilized and blocked
with 0.3% Triton X-100/10% normal goat serum (NGS, Invi-
trogen) in 0.01 M PBS (pH 7.4) for 30 min, and primary
antibodies were then applied to the sections overnight at
4 C. The following day, sections were incubated with
fluorescein-conjugated secondary antibodies (Alexa 568
goat antimouse [1:400] or Alexa 488 goat antirabbit
[1:400], both from Invitrogen) for 1 h at room temperature
before mounting with antifade mounting medium. The fol-
lowing primary antibodies were used: monoclonal mouse
anti-NeuN Ab (1:100, Millipore), monoclonal mouse anti-
chondroitin sulfate proteoglycan (CSPG) Ab (1:200,
Millipore), polyclonal rabbit anti-GFAP Ab (1:100, Sigma-
Aldrich), mouse anti-NF200 Ab (1:100, Sigma-Aldrich), and
mouse anti-ED1 Ab (1:100, Serotec).
After immunohistochemistry (IHC) staining, 5 sections
were randomly selected from each sample for taking pictures.
The size of areas taken by positive GFP, NeuN, NF200,
GFAP, and ED1 staining and the size of whole picture were
measured using ImageJ software (NIH) as mentioned above.
When measuring the size of the spinal cord in the selected
sections, the blank area around the spinal cord should be
deleted before measuring. Then the ratios of these positive
staining areas to the area of spinal cord were calculated.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism ver-
sion 6.01 software (GraphPad Software, La Jolla, CA, USA).
All data were expressed as mean + standard deviation. The
difference between 2 groups was compared using t-test. One-
way analysis of variance was used for the analysis of multiple
groups, and q-test was used for pair comparison between
groups. A P < 0.05 was considered statistically significant.
Results
Survival and Migration of Transplanted NSCs
in Tibial Nerve
One week after injection, transplanted GFP-positive NSCs
survived well in tibial nerve, which showed green color
under fluorescence microscope (Fig. 1). On tibial nerve
longitudinal section, NSCs migrated along the axons to both
ends (Fig. 1A and C). On tibial nerve cross section, most
transplanted NSCs located in the injection area, though some
cells migrated through the small clearances among axons.
Depending on the morphology, NSCs survived well inside
tibial nerve in both NS and LiCl groups.
Differentiation of Transplanted NSCs in Tibial Nerve
One week after transplanted into tibial nerve, transplanted
NSCs showed strong GFP-positive expression. However, no
obvious nestin-positive expression was seen in either control
or LiCl group (Fig. 2A), as well as the NeuN or ChAT (data
not shown), indicating that most NSCs differentiated after
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being transplanted into tibial nerve but not NeuN- or ChAT-
positive neurons.
One week after transplantation, after GFAP staining, both
control and LiCl groups had massive positive GFAP staining.
Almost all GFAP-positive area was confined inside GFP-
labeled area. In the control group, most of the GFAP-positive
area overlapped with GFP-positive area (Fig. 2B–D). How-
ever, in LiCl group, the GFAP-positive area is smaller and had
lesser overlapped area with GFP-labeled area (Fig. 2F–H).
Measuring the size of GFAP-positive area and calculating
the percentage of GFAP-positive area to the GFP-positive
area, the percentages of control and LiCl groups were 86.7%
+ 13.8% and 69.8% + 8.2%, respectively. LiCl group is
much smaller than the control group (P < 0.05, Fig. 2E).
Inflammatory Cell Infiltration in Tibial Nerve
of Different Groups
One week after NSC injection, populous ED1-positive
macrophage infiltration was seen in both NSC þ normal
saline (NS) group (Fig. 3B) and NSC þ LiCl group (Fig.
3E). Most of the macrophage infiltration occurred around the
injected NSCs (NSC + NS group, Fig. 3A, C and NSC + LiCl
group, Fig. 3D, F). The ED1-positive cover rates of NSC þ
NS and NSCþ LiCl group were 8.97%+ 4.07% and 6.31%
+ 2.78%, respectively. The ED1 expression of NSC þ LiCl
group was lower than NSC þ NS group, showing a signif-
icant difference (P < 0.01; Fig. 3G), indicating that lithium
may suppress inflammation caused by NSC injection.
Outcome of Rat Hind Limb Function
Two weeks after tibial nerve transplantation, only little func-
tional recovery was seen in all groups. The animals in tibial
nerve transplantation (TN) þ NSC þ LiCl group recovered
best; recovery in both TN þ NSC þ NS and TN þ LiCl
groups was fair, while TN þ NS group recovery was the
worst. The BBB scores of different groups are listed in Table
1. The BBB score of TN þ NSC þ LiCl group was higher
than other groups (P < 0.01); the BBB score of TNþ NSCþ
NS group was a little higher than TN þ LiCl group, but no
difference was found after statistical analysis. The BBB
Fig. 1. The survival of transplanted neural stem cells (NSCs) in tibial nerve. (A, B) Longitudinal and cross section of tibial nerve of control
group; (C, D) longitudinal and cross section of tibial nerve of LiCl group. Transplanted NSCs survived well inside tibial nerve.
Fig. 2. Differentiation of transplanted neural stem cells (NSCs) in tibial nerve. (A) No obvious nestin-positive expression was observed;
(B–D) control group; (E) comparison of glial fibrillary acidic protein (GFAP)-positive areas in different groups; and (F–H) lithium chloride
(LiCl) group. (B, F) NSCs that expressed green fluorescent protein (GFP) are shown in green color; (C, G) the GFAP-positive staining area of
both control and LiCl group. The LiCl group had smaller GFAP-labeled area (E); (D, H) merged picture shows most GFAP-positive area of
overlap with GFP-labeled area in control group. White arrow shows GFAP-negative area. *Compared with control group, P < 0.05.
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score of TN þ NS group was lower than other groups, show-
ing a significant difference (P < 0.05; Table 1, Fig. 4).
Four weeks after tibial nerve transplantation, more right–
hind limb functional recovery was seen in all groups. The ani-
mals in TN þ NSC þ LiCl group recovered best. Four-week
recovery in both TNþ NSCþ NS and TNþ LiCl groups was
much better than at 2 wk. TN þ NS group recovered to some
extent as well, but still not as well as other groups. The BBB
scores of different groupswere as follows:TNþNSgroup: 6.17
+ 1.60; TN þ LiCl group: 8.33 + 1.03; TN þ NSC þ NS
group: 8.67+ 1.75; and TN þ NSC þ LiCl group: 12.17+
1.72. After statistical analysis, the BBB score of TN þ NSCþ
LiCl group was higher than other groups (P < 0.01). The BBB
scores of TN þ NSC þ NS group and TN þ LiCl group were
higher than TN þ NS group (P < 0.05; Table 1, Fig. 4), but no
significant difference was found between these 2 groups.
Differentiation of NSCs in Tibial Nerve
after Transplantation
Four weeks after the transplantation of tibial nerve with
NSCs, the transplanted NSCs survived well, expressing
GFP protein with bright green color (Fig. 5A and B).
There were more bright green labeled NSCs in TN þ
NSC þ LiCl group (Fig. 5B) than in TN þ NSC þ NS
group (Fig. 5A), with an average GFP positive area ratio
of 1.762% + 0.193% and 0.972% + 0.182%, respec-
tively (Fig. 5C, P < 0.01). In the lithium-treated group,
transplanted NSCs sent out many long neurites, which
grew into host parenchyma (Fig. 5D–F) and had direct
contact with host neuron (Fig. 5F, upper-right box). The
longest neurite measured was 0.4 mm (Fig. 5F, arrow).
No neurite was found in TN þ NSC þ NS group.
Four weeks after the transplantation of tibial nerve
with NSCs, no nestin expression was found in trans-
planted NSCs. Some NSCs in the LiCl-treated group
express NF200 (Fig. 5G–I). However, no NeuN- or
ChAT-positive differentiated neuron was found in trans-
planted NSCs. No neuron differentiation was found in the
control group.
Table 1. Blood Born Barrier Score at 2 and 4 Wk after Transplan-
tation of Different Groups.
Groups
Two Week after
Transplantation
Four Week after
Transplantation
TN þ NS group 2.83 + 1.17 6.17 + 1.60
TN þ LiCl group 4.33 + 1.03* 8.33 + 1.03*
TN þ NSC þ NS group 4.50 + 1.05* 8.67 + 1.75*
TN þ NSC þ LiCl group 6.17 + 0.75** 12.17 + 1.72**
Abbreviations: NSC ¼ neural stem cell; LiCl ¼ lithium chloride.
*Compared with TN + NS group, P < 0.05.
**Compared with other groups, P < 0.01.
Fig. 4. Comparison of blood born barrier scores at different times
after surgery of all groups *Compared with TNþNS group, P < 0.05.
Fig. 3. The expression of ED1 in tibial nerve after neural stem cell (NSC) injection. (A–C) NSCþ NS group; (D, E) NSC þ lithium chloride
group. (A, D) green fluorescent protein (GFP)-labeled NSCs; (B, E) ED1 expression in tibial nerve; (C, F) merged picture showing
macrophages distributed around implanted NSCs; (G) the ED1-positive ratio in tibial nerve of different groups. *Compared with NSC þ
NS group, P < 0.05.
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Survival of Host Spinal Cord Motoneurons after
NSC Transplantation
Four weeks after tibial nerve transplantation, the numbers of
host neurons in the left side of spinal cord and beyond the
glial scar of all groups were close to normal. In TN þ NS
group, the number of NeuN-positive neurons in the injury
side significantly decreased (Fig. 6A). The number of host
neurons in the injury side decreased in TN þ LiCl and TNþ
NSC þ NS groups (Fig. 6B and C), while in TN þ NSC þ
LiCl group, only a few host neurons died in the injured side
beyond the glial scar (Fig. 6D).
The numbers of host neurons of both sides were counted
in coronal sections, and the ratios of neuron number on the
injured side to the other side of different groups were as
follows: TNþ NS group: 47.8%+ 8.6%; TNþ LiCl group:
62.9% + 7.3%; TN þ NSC þ NS group: 61.0% + 9.3%;
and TN þ NSC þ LiCl group: 74.1%+ 6.1%. After statis-
tical analysis, the ratio of neuron number on the injured side
to the neuron number on the other side in TN þ NS group
was significantly lower than other groups (P < 0.01; Fig. 6E).
The ratios in TN þ LiCl group and TN þ NSC þ NS group
were similar, higher than that of TN þ NS group (P > 0.05;
Fig. 6E). The neuron number ratio in injured side of TN þ
NSC þ LiCl group is much higher than the 3 other groups
(Fig. 6E).
Axonal Regeneration after Tibial Nerve
Transplantation in Different Groups
Four weeks after transplantation, transplanted tibial nerve
integrated well into host spinal cord, and NF200-positive
regenerated axons could be found in all groups. In TN þ
NS group, only a few NF200-positive axons were found
(Fig. 7A), while more regenerated axons were found in
TN þ LiCl group (Fig. 7B), TN þ NSC þ NS group (Fig.
7C), and TN þ NSC þ LiCl group (Fig. 7D). Most of the
regenerated axons were found in both ends of trans-
planted tibial nerve and in host spinal cord near the
host–implant interface. In TN þ NSC þ LiCl group,
intensive regenerated axons were found inside the
implanted tibial nerve (Fig. 7D).
Fig. 5.Differentiation of transplanted neural stem cells (NSCs) in tibial nerve in host spinal cord after spinal cord injury. (A–C) Transplanted
NSCs survived well; (D) NSCs in TNþNSCþ lithium chloride (LiCl) group sent out long neurites (arrow) and grew into host parenchyma;
(E) host motoneurons (hollow arrow); and (F) merged picture. Upper right is magnified picture of dotted box in the middle. A contact of
regenerated axon with host neuron can be seen (arrow head); (G) green fluorescent protein (GFP)-positive NSCs; (H) NF200-positive
expression in cell body and neurites; (I) merged picture indicates double-labeled cells showing yellow color (arrow).
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We measured the NF200-positive staining covered area
using ImageJ software and calculated the ratio of NF200-
positive area to whole visual field. The ratios in all groups
were as follows: TN þ NS group: 4.87% + 1.21%; TN þ
LiCl group: 8.36% + 2.27%; TN þ NSC þ NS group:
13.47% + 2.85%; and TN þ NSC þ LiCl group: 17.93%
+ 2.59%. After analysis, the NF20-covered ratio increased
dramatically from TN þ SC group to TN þ NSC þ LiCl
group, and there were significant differences among all these
groups (Fig. 7E).
Fig. 7. The expression of NF200 in implanted tibial nerve and host spinal cord 4 wk after transplantation. Asterisks indicate implanted tibial
nerves, while white dotted lines indicate host-implant interfaces. (A) TN þ NS group, only a few regenerated axons were found. (B) TN þ
lithium chloride (LiCl) group. (C) TN þ neural stem cell (NSC) þ NS group, more regenerated axons were found in tibial nerve and host
spinal cord. (D) TN þ NSC þ LiCl group, numerous parallel regenerated axons were found in implanted tibial nerve and host-implant
interface. (E) The NF200-covered area ratio of different groups 4 wk after transplantation. yCompared with TN þ NS group, P < 0.05;
yycompared with TNþNSCþ LiCl group, P < 0.01; ##compared with TNþNS group, P < 0.01; #compared with TNþ LiCl group, P < 0.05;
**compared with TN þ NS group, P < 0.01; *compared with TN þ NSC þ NS group, P < 0.05.
Fig. 6. The number of host neurons on both sides of spinal cord of different groups as injured side on the lower right. Asterisks indicate the
injured side of spinal cord, while white dotted lines indicate the midline of spinal cord. (A) TNþNS group; (B) TNþ lithium chloride (LiCl)
group; (C) TN þ neural stem cell (NSC) þ NS group; (D) TN þ NSC þ LiCl group; and (E) the neuron number ratio of injured side in
different groups. *Compared with TNþNS group, P < 0.05; **compared with TNþNS group, P < 0.01; ycompared with TNþ LiCl and TN
þ NSC þ NS group, P < 0.05.
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Expression of CSPG in Different Groups
Four weeks after tibial nerve transplantation, numerous
strong CSPG-positive expressions were found in the area
of transplanted tibial nerve in host spinal cord in control
group without NSCs and lithium injection (TN þ NS group;
Fig. 8A). The expression of CSPG significant decreased in
animal with lithium injection (TN þ LiCl group; Fig. 8B) or
with NSCs transplantation (TN þ NSC þ NS group; Fig.
8C). Only few CSPG-positive staining was found scattered
around the grafted area in animal with NSCs transplantation
and lithium injection (TN þ NSC þ LiCl group; Fig. 8D).
Expression of GFAP and Tissue Reaction after SCI
in Different Groups
Four weeks after tibial nerve transplantation, massive
GFAP-positive expression was found in the glial scar that
surrounded the reaction area in all groups. The GFAP-
positive glial scar-surrounded tissue reaction area was most
extended in TN þ NS group (Fig. 9A), while the reaction
area was reduced in TN þ LiCl group and TN þ NSC þ NS
group (Fig. 9B and C). The tissue reaction area in TNþNSC
þ LiCl group was the smallest of all groups (Fig. 9D).
We measured the tissue reaction area that surrounded
GFAP-positive glial scar. The reaction areas of different
groups were as follows: TN þ NS group: 9.46+ 1.03 mm2;
TNþ LiCl group: 7.22+ 1.16mm2; TNþNSCþNS group:
6.56+ 1.25 mm2; and TN þ NSC þ LiCl group: 4.97 +
1.03 mm2. After statistical analysis, TN þ NS group had
the largest reaction area (P < 0.01; Fig. 9E). Tissue reac-
tion areas of TN þ LiCl group and TN þ NSC þ NS
group were smaller and had no difference between these 2
groups, while the reaction area of TN þ NSC þ LiCl
group was significantly smaller than the other 3 groups
(P < 0.05; Fig. 9E).
Expression of ED1 in Different Groups after SCI
Four weeks after tibial nerve transplantation, massive ED1-
positive expression was found inside or outside the reaction
area in all groups. In TN þ NS group, massive macrophage
infiltration was found in the injured spinal cord (Fig. 10A),
while in TNþ LiCl group and TNþNSCþNS group, ED1-
positive macrophage-infiltrated areas were decreased (Fig.
10B and C). The ED1-positive area in TN þ NSC þ LiCl
group was smaller than any other group (Fig. 10D).
We measured the ED1-positive area in coronal sections,
and the ED1-covered areas of different groups were as fol-
lows: TN þ NS group: 3.93+ 0.96 mm2; TNþ LiCl group:
2.77 + 1.14 mm2; TN þ NSC þ NS group: 2.46 + 0.71
mm2; and TNþNSCþ LiCl group: 1.81+ 0.61 mm2. After
statistical analysis, TN þ NS group had the largest
macrophage-infiltrated area (Fig. 10E). ED1-covered areas
in TN þ LiCl group and TN þ NSC þ NS group were
Fig. 8. Expression of chondroitin sulfate proteoglycan (CSPG) in different groups. (A) TN þ NS group, strong CSPG-positive expression
was found in the area of transplantation of tibial nerve in host spinal cord; (B) TNþ lithium chloride (LiCl) group; (C) TNþ neural stem cell
(NSC) þ NS group; and (D) TN þ NSC þ LiCl group.
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smaller (Fig. 10E). It looked like the TN þ NSC þ LiCl
group had the smallest ED1-covered area of all the groups.
However, statistical analysis revealed no significant differ-
ences among TNþ LiCl group, TNþNSCþNS group, and
TN þ NSC þ LiCl group (Fig. 10E).
Discussion
The goal of this study was to determine whether the trans-
plantation of NSCs or LiCl injection or both would have any
effect on the axonal regeneration and functional recovery
after SCI. Our results demonstrate that both NSCs and LiCl
significantly suppress traumatic inflammation, reduce host
neuron death and tissue damage, and promote axonal regen-
eration and functional recovery. In addition, lithium
enhances neuronal differentiation of transplanted NSCs.
These 2 therapies in combination could, therefore, produce
better results in the treatment of SCI.
Fig. 9. Tissue reaction area surrounded by glial fibrillary acidic
protein-positive glial scar in different groups 4 wk after tibial trans-
plantation. (A) TN þ NS group; (B) TN þ lithium chloride (LiCl)
group; (C) TN þ neural stem cell (NSC) þ NS group; (D) TN þ
NSC þ LiCl group; and (E) comparison of the reaction area of
different groups. *Compared with TN þ LiCl and TN þ NSC þ
NS groups, P < 0.05; ycompared with TN þ NS group, P < 0.01.
Fig. 10. Expression of ED1 in different groups. (A) TNþNS group,
massive macrophage infiltration was found in spinal cord; (B) TN þ
lithium chloride (LiCl) group; (C) TN þ neural stem cell (NSC) þ
NS group; (D) TN þ NSC þ LiCl group; and (E) comparison of
ED1-labeled area in different groups. *Compared with TN þ NS
group, P < 0.05; ycompared with TN þ NS group, P < 0.01.
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Lithium Enhances Survival and Neuronal
Differentiation of Transplanted NSCs
In our study, we first inject NSCs into the distal part of
transected tibial nerve. One week after transplantation, no
expression of nestin, NF200, NeuN, or ChAT was found in
NSCs, while most of the NSCs were positive for GFAP
expression. LiCl injection reduced GFAP expression but has
no effect on other factors. As we know, peripheral nerve
injury involvesWallerian degeneration, myelin collapse, and
Schwann cell proliferation25. Schwann cells secrete large
amounts of neurotrophic factors to promote repair of nerve
injury, including BDNF, GDNF, and so on26. Although
BDNF has a positive effect on neuronal differentiation of
NSCs27, the effects of BDNF may be overtaken by other
cells and cytokines inside damaged peripheral nerve, which
could induce NSCs to differentiate into other cell types
instead of neurons. It was reported that, under certain con-
ditions, NSCs can differentiate into endothelial cells28 and
myocytes29.
When NSCs were transplanted into an SCI gap via tibial
nerve with 4 wk of LiCl intervention, more NSCs survived
and some NSCs differentiated into neuron-like cells expres-
sing NF200. It has been reported that transplanted NSCs can
differentiate into astrocytes and neurons after SCI30–32.
Kim’s study confirmed that LiCl promotes cultured hippo-
campal neural progenitor cells (NPCs) differentiation into a
calbindin-positive neuronal cell type33. Su’s study showed
LiCl contributes to transplanted NSCs differentiation into
NeuN-positive neurons in normal spinal cord27. Our experi-
ment showed that these differentiated neurons may come
from GFAP-negative cells within transplanted NSCs. Since
neuronal differentiation of NSCs takes time, the results of
studies mentioned above were observed several months after
transplantation. When LiCl intervention was extended; how-
ever, the local microenvironment could be improved and
made suitable for the differentiation of NSCs into neurons.
In addition, LiCl promotes the survival and neuronal differ-
entiation of transplanted NSCs, which may be conducted
through promoting NSCs’ secretion of BDNF34.
Lithium and NSC Suppress Trauma-related
Inflammation and Preserve More Spared Tissue
In the setting of inflammatory cell infiltration that ensues
after SCI, the expression of many inflammatory cytokines,
including tumor necrosis factor (TNF)-a, interleukin (IL)-
1a, IL-1b, and IL-1, was significantly increased35. The
cytotoxicity of these inflammatory cytokines can lead to
apoptosis of neurons and oligodendrocytes. In acute SCI,
macrophages and lymphocytes that infiltrate injured tissues
secrete TNF and other neurotoxic factors, resulting in
demyelination and axonal degeneration36. Astrocytes and
microglial cells can inhibit anti-inflammatory cytokine IL-
10 expression by synthesis of a variety of proinflammatory
cytokines (for instance, IL-6 and TNF), inflammatory
chemokines, and nitric oxide via the glycogen synthase
kinase 3 (GSK-3) pathway37. Increased IL-6 expression can
act on endogenous NSCs, leading to their differentiation into
reactive astrocytes and expressed CSPG38, which, in turn,
inhibit axonal regeneration39.
In our study, we found that there was still significant local
macrophage infiltration even 4 wk after transplantation.
Compared with the group with tibial nerve transplantation
only, macrophage infiltration into the spinal cord in the other
3 groups was less, while animals treated with NSCs and LiCl
had the least ED1 staining, indicating both NSCs and LiCl
could inhibit inflammatory response after transplantation.
Lithium is a direct inhibitor of GSK-3 by phosphorylation
of serine, which inhibits the activity of GSK and, thus, sup-
presses inflammation40,41. Lithium also can reduce
inflammation-induced neurotoxicity and reduce ischemia-
related nerve damage42. A recent study has shown that
long-term use of lithium can reduce p105 content in macro-
phages and inhibit lipopolysaccharide (LPS)-mediated
NF-kB activation, which results in macrophage apoptosis43.
De Meyer found that therapeutic doses of LiCl inhibit the
enzyme inositol monophosphate and induce cultured macro-
phage apoptosis44. In addition, lithium’s ability to upregulate
the expression of BDNF can also indirectly control the activ-
ity of GSK so as to suppress inflammation45. The coordi-
nated effects of lithium and NSCs on the inhibition of
inflammation and macrophage activity benefit both tissue
repair and axon regeneration46.
It was reported that lithium inhibits macrophage activity
by inhibiting LPS or inositol monophosphate43,44. Ben-Hur
found that intraventricular transplantation of NPCs or intra-
venous NPC injection attenuated brain inflammation in
acute and chronic encephalomyelitis by suppressing T-cell
chemical substances46. Busch also found that multipotent
progenitor cells significantly decrease matrix
metalloproteinase-9 release from macrophages, effectively
preventing induction of axonal dieback47.
Lithium and NSC Suppress Glial Scar Formation
Our results also suggest that decreased traumatic inflamma-
tion may be accompanied by reduced glial scar formation. In
our study, tibial nerve transplantation with NSCs or LiCl
injection after SCI results in smaller tissue reaction area than
transplantation with tibial nerve only, and the combination
of NSC transplantation and LiCl injection results in the
smallest reaction area, indicating that either NSC transplan-
tation or LiCl injection could inhibit glial scar formation. It’s
well known that CSPG plays an important role in glial scar
formation after SCI48 and accounts for inhibition of axonal
regeneration49. Our results showed that both NSCs trans-
plantation and lithium injection can reduce CSPG expression
after SCI, which in accordance with the suppressed glial scar
formation. Lithium has been reported to have neuroprotec-
tive effects in CNS injury and degenerative diseases. Yu
applied LiCl in the treatment of brain injury, and there were
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significantly smaller damaged areas after LiCl treatment50.
Hwang transplanted NSCs transfected with Olig2 gene after
SCI, resulting in better white matter sparing and reduced
cavity formation51. Gilad’s study showed that LiCl could
reduce ornithine decarboxylase to enhance neuronal survival
but inhibits astroglial growth, at the same time promoting
transformation of astroglia from epithelioid (flat) to process-
bearing morphology cells52. The results of our study support
the idea that LiCl inhibits the functions of astrocytes and
reduces the glial scar formation. However, the effect of NSC
and lithium on the expression of CSPG after SCI needs
further investigation.
Effect of Lithium and Transplanted NSCs
on Host Neurons
In this study, we also investigate the effects of NSC trans-
plantation and LiCl injection on host spinal neurons. Our
results showed that, 4 wk after transplantation, there were
more NeuN-expressing neurons spared both rostrally and
caudally next to the site of injury of host spinal cord with
NSC transplantation and/or LiCl injection compared with
those without NSCs/LiCl intervention. This result indicates
that the combination strategy of transplantation of NSCs and
application of LiCl after SCI also have a protective effect on
the host’s own motor neurons.
The possible mechanisms for the protection of host neu-
rons by transplanted NSCs and LiCl include (1) LiCl directly
inhibiting GSK-3 by phosphorylation of GSK-353, or indi-
rect inhibition of GSK-3 by activating PI3K and Akt-1,
thereby activating the b-catenin pathway15, reducing the
death of neurons; (2) Our results showed the transplantation
of NSCs and application of LiCl significantly inhibit macro-
phage infiltration, which also plays an important role in
protecting host neurons; and (3) B cell lymphoma protein-
2 (Bcl-2) pathway may also be involved in the survival of
neurons. In CNS injury, Bcl-2 can protect neurons from
apoptosis; and chronic administration of lithium dramati-
cally increases the expression of Bcl-2 protein in nucleus
magnocellularis neurons54,55.
Effect of Lithium and NSCs on Axonal Degeneration
and Regeneration
In peripheral nerve injury, Wallerian degeneration occurs in
the distal part of the affected nerve and proceeds in steps of
axonal degeneration, myelin breakdown, macrophage infiltra-
tion, and removal of myelin and axon debris. In our study,
when tibial nerve with NSCs was transplanted into the injured
area of the spinal cord, the number of regenerated axons was
higher in groups that received NSC transplantation and/or
LiCl injection compared with the group with tibial nerve
transplantation only at 4 wk after surgery. There were more
regenerated axons in animals receiving NSC transplantation
alone than receiving LiCl injection alone, and the combined
application of NSCs and LiCl injection resulted in the best
axonal regeneration. A recent study showed that transplanta-
tion of NSCs promotes axonal regeneration after SCI56, and
the combination of neurotrophic factors, such as BDNF and
GDNF, had better effects on axonal regeneration57–59.
It was reported that NSCs promote axonal regeneration by
reducing CSPG immunoreactivity in the extracellular matrix
in injured peripheral nerve12. The CSPG resulting from CNS
injury can activate the GSK-3 signaling pathway to inhibit
axonal regeneration60. LiCl can upregulate GSK-3 phos-
phorylation, inhibit GSK-3, and promote axonal growth61.
The increase in the number of axons spared by LiCl injec-
tion may also relate to its inhibition of inflammatory
response. In our study, ED1 expression in tibial nerve was
much less after LiCl intervention compared to the control
group, indicating that both NSC transplantation and LiCl
intervention inhibit the inflammatory response after nerve
injury. In addition, there are more preserved host motoneur-
ons after the application of NSCs and LiCl, and these neu-
rons may go on to sprout more axons that are able to grow
into transplanted tibial nerve.
Therefore, in this experiment, in addition to its known
ability to inhibit GSK-3, lithium could promote the synthesis
of BDNF in transplanted NSCs and promote axonal
regeneration.
Effect of Lithium and NSCs on Functional
Recovery after SCI
In our study, 2 and 4 wk after NSC transplantation, the BBB
scores were higher in animals that received either NSC trans-
plantation or LiCl injection than those that received tibial
nerve transplantation only. These results show that after SCI,
the transplantation of NSCs or injection of LiCl can signif-
icantly promote functional recovery of lower limb in rats,
and treating with both could produce better results, in accor-
dance with the enhancement of axonal regeneration
explained above. Given together, NSC transplantation and
LiCl injection significantly inhibit glial cell response after
SCI, decrease macrophage infiltration, reduce glial scar for-
mation, preserve more spared neural tissue and host neurons,
promote axonal regeneration, and, finally, result in better
recovery of motor function.
In summary, we provide evidence that lithium can
enhance the NF200-positive neuron differentiation of trans-
planted NSCs in tibial nerve and that concomitant treatment
with NSC transplantation and LiCl injection promotes axo-
nal regeneration and functional recovery in spinal cord hemi-
sectioned rats. The combination of NSC transplantation and
LiCl injection may represent an effective strategy for pro-
moting axonal regeneration in the injured spinal cord.
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